Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivo
Jessica Perrin(GlaxoSmithKline (Germany)), Giovanna Bergamini(Heidelberg Engineering (Germany)), Daniel C. Sévin(GlaxoSmithKline (Germany)), Wolfgang Huber(European Molecular Biology Laboratory), Katrin Strohmer(GlaxoSmithKline (Germany)), Maria Faelth-Savitski(GlaxoSmithKline (Germany)), Thilo Werner(GlaxoSmithKline (Germany)), Mathias Kalxdorf(German Cancer Research Center), Bianca Heller(GlaxoSmithKline (Germany)), Jana Krause(GlaxoSmithKline (Germany)), H. Christian Eberl(GlaxoSmithKline (Germany)), Douglas W. Thomson(GlaxoSmithKline (Germany)), Marcus Bantscheff(Roche (Switzerland)), Christina Rau(GlaxoSmithKline (Germany)), Eugenia Stonehouse(GlaxoSmithKline (Germany)), Daniel Poeckel, Johanna Vappiani(Diabetesinstitut Heidelberg), Nils Kurzawa(Institute for Research in Biomedicine), Anna Rutkowska(GlaxoSmithKline (Germany)), Mikhail M. Savitski(European Molecular Biology Laboratory), Holger Franken(GlaxoSmithKline (Germany)), Dorothee Childs(European Molecular Biology Laboratory)
Cited by 5
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k